Vallon Pharmaceuticals Inc (VLON)
NASDAQ
The current VLON market cap is 1.3M. The company's latest EPS is USD -4.0163 and P/E is -0.10.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.57M | -2.44M | -2.03M | -1.9M | -2.26M |
Net Income | -6.5M | -2.14M | -2M | -1.89M | -2.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 100k | 0 | 0 | 0 |
Operating Income | -3.15M | -4.79M | -9.26M | -6.93M | -11.39M |
Net Income | -3.46M | -4.82M | -9.3M | -7.02M | -13.04M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.64M | 4.4M | 2.96M | 4.59M | 7.03M |
Total Liabilities | 1.6M | 2.18M | 2.7M | 1.79M | 2.31M |
Total Equity | 4.04M | 2.23M | 259k | 2.8M | 4.72M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.28M | 955k | 8.34M | 4.15M | 2.96M |
Total Liabilities | 1.06M | 2.41M | 2.52M | 1.81M | 2.7M |
Total Equity | 3.21M | -1.45M | 5.82M | 2.34M | 259k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.12M | -3.43M | -8.99M | -2.2M | -4.34M |
Investing | -8k | -8k | -8k | N/A | N/A |
Financing | 6.92M | 6.92M | 10.8M | 4.49M | 8.89M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.88M | -3.71M | -8.31M | -7.14M | -8.99M |
Investing | N/A | -2k | -3.84M | 3.78M | -8k |
Financing | 6.09M | -4k | 15.75M | 3.43M | 10.8M |
Market Cap | 1.3M |
Price to Earnings Ratio | -0.10 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.72 |
Price to Book Ratio | 5.01 |
Dividend Yield | - |
Shares Outstanding | 3.25M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (2.38%) |
Company Name | Vallon Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://vallonpharmaceutical |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.